OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101. A total of 33 filers reported holding OSMOTICA PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $103 | -84.5% | 1,187 | 0.0% | 0.00% | – |
Q2 2023 | $665 | -50.8% | 1,187 | 0.0% | 0.00% | – |
Q1 2023 | $1,353 | +35.3% | 1,187 | 0.0% | 0.00% | – |
Q4 2022 | $1,000 | -50.0% | 1,187 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 1,187 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 1,187 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 1,187 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -80.0% | 1,187 | -29.6% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 1,687 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | 0.0% | 1,687 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -14.3% | 1,687 | 0.0% | 0.00% | – |
Q4 2020 | $7,000 | -22.2% | 1,687 | 0.0% | 0.00% | – |
Q3 2020 | $9,000 | – | 1,687 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 8,148,832 | $8,801,000 | 3.14% |
Rovida Advisors Inc. | 3,000,000 | $3,210,000 | 0.14% |
Zebra Capital Management LLC | 24,384 | $26,000 | 0.04% |
TITLEIST CAPITAL, LLC | 80,184 | $87,000 | 0.02% |
Alyeska Investment Group, L.P. | 1,125,689 | $1,216,000 | 0.01% |
ArrowMark Colorado Holdings LLC | 1,000,000 | $1,080,000 | 0.01% |
Insight Advisors, LLC/ PA | 24,800 | $27,000 | 0.01% |
Renaissance Technologies | 1,355,774 | $1,464,000 | 0.00% |
Engineers Gate Manager LP | 42,810 | $46,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 249,851 | $270,000 | 0.00% |